PSEN1 and familial Alzheimer disease: This is in line with other in vitro studies showing that fAD-linked mutations in PSEN1 can lead to reduced levels of individual Aβ peptides, with particularly low or even undetectable levels of Aβ40 (Sun et al., 2017).